Search by Drug Name or NDC

    NDC 66302-0350-02 Orenitram 5 mg/1 Details

    Orenitram 5 mg/1

    Orenitram is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by United Therapeutics Corporation. The primary component is TREPROSTINIL.

    Product Information

    NDC 66302-0350
    Product ID 66302-350_e9babc9a-fe4f-4da1-9110-4425b17f2381
    Associated GPIs 40170080050435
    GCN Sequence Number 077482
    GCN Sequence Number Description treprostinil diolamine TABLET ER 5 MG ORAL
    HIC3 B1C
    HIC3 Description PULMONARY ANTIHYPERTENSIVES, PROSTACYCLIN-TYPE
    GCN 43521
    HICL Sequence Number 040827
    HICL Sequence Number Description TREPROSTINIL DIOLAMINE
    Brand/Generic Brand
    Proprietary Name Orenitram
    Proprietary Name Suffix n/a
    Non-Proprietary Name treprostinil
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name TREPROSTINIL
    Labeler Name United Therapeutics Corporation
    Pharmaceutical Class Prostacycline Vasodilator [EPC], Prostaglandins I [CS], Vasodilation [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA203496
    Listing Certified Through 2024-12-31

    Package

    NDC 66302-0350-02 (66302035002)

    NDC Package Code 66302-350-02
    Billing NDC 66302035002
    Package 1 BLISTER PACK in 1 CARTON (66302-350-02) / 10 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2021-06-30
    NDC Exclude Flag N
    Pricing Information N/A